165 related articles for article (PubMed ID: 11577261)
1. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.
Atar S; Luo H; Birnbaum Y; Nagai T; Siegel RJ
J Thromb Thrombolysis; 2001 May; 11(3):223-8. PubMed ID: 11577261
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ
Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468
[TBL] [Abstract][Full Text] [Related]
3. Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.
Atar S; Neuman Y; Miyamoto T; Chen M; Birnbaum Y; Luo H; Kobal S; Siegel RJ
J Thromb Thrombolysis; 2003 Jun; 15(3):165-9. PubMed ID: 14739625
[TBL] [Abstract][Full Text] [Related]
4. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study.
Wyshelesky A; Iakobishvili Z; Matz I; Golovchiner G; Vaturi M; Siegel RJ; Birnbaum Y
Thromb Res; 2001 Aug; 103(4):337-44. PubMed ID: 11562343
[TBL] [Abstract][Full Text] [Related]
5. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots.
Meunier JM; Holland CK; Pancioli AM; Lindsell CJ; Shaw GJ
Thromb Res; 2009; 123(3):528-36. PubMed ID: 18619651
[TBL] [Abstract][Full Text] [Related]
6. In vitro ultrasound augmented clot dissolution--what is the optimal timing of ultrasound application?
Shlamovitz GZ; Iakobishvili Z; Matz I; Golovchiner G; Lev E; Siegel RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2002 Dec; 16(6):521-6. PubMed ID: 12766386
[TBL] [Abstract][Full Text] [Related]
7. Sonothrombolysis is effective with recombinant tissue-type plasminogen activator, but not with Abciximab. Results from an in vitro study with whole blood clots and platelet-rich clots.
Eggers J; Ossadnik S; Hütten H; Seidel G
Thromb Haemost; 2009 Dec; 102(6):1274-7. PubMed ID: 19967161
[TBL] [Abstract][Full Text] [Related]
8. Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapy.
Holmes MB; Schneider DJ; Hayes MG; Sobel BE; Mann KG
Circulation; 2000 Oct; 102(17):2051-7. PubMed ID: 11044419
[TBL] [Abstract][Full Text] [Related]
9. Comparative antithrombotic effects of magnesium sulfate and the platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis.
Rukshin V; Shah PK; Cercek B; Finkelstein A; Tsang V; Kaul S
Circulation; 2002 Apr; 105(16):1970-5. PubMed ID: 11997285
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
11. The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound.
Adler Y; Attar D; Vaturi M; Golovchiner G; Iakobishvili Z; Battler A; Siegel RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2001 Mar; 15(2):119-23. PubMed ID: 11669404
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effect of diagnostic ultrasound on enzymatic thrombolysis. An in vitro study on blood of normal subjects and patients with coronary artery disease.
Basta G; Lupi C; Lazzerini G; Chiarelli P; L'Abbate A; Rovai D
Thromb Haemost; 2004 Jun; 91(6):1078-83. PubMed ID: 15175792
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An ex-vivo canine shunt study.
Neuman Y; Rukshin V; Tsang V; Atar S; Miyamoto T; Luo H; Kobal S; Thompson T; Birnbaum Y; Horzewski M; Siegel RJ; Kaul S
Thromb Res; 2003; 112(1-2):99-104. PubMed ID: 15013280
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of low-frequency ultrasound-induced clot disruption by hydroxyethyl starch is dependent on the duration and intensity of ultrasound exposure; an in vitro study.
Adler Y; Dagan A; Golovchiner G; Iakobishvili Z; Matz I; Lev E; Siegel RJ; Birnbaum Y
Ultrasound Med Biol; 2003 Mar; 29(3):483-6. PubMed ID: 12706200
[TBL] [Abstract][Full Text] [Related]
15. High intensity, low frequency catheter-delivered ultrasound dissolution of occlusive coronary artery thrombi: an in vitro and in vivo study.
Steffen W; Fishbein MC; Luo H; Lee DY; Nita H; Cumberland DC; Tabak SW; Carbonne M; Maurer G; Siegel RJ
J Am Coll Cardiol; 1994 Nov; 24(6):1571-9. PubMed ID: 7930293
[TBL] [Abstract][Full Text] [Related]
16. Efficiency in clinical research: assessment in vitro of potential anti-thrombotic drug interactions.
Schneider DJ; Whitaker DA; Sobel BE
Coron Artery Dis; 2004 May; 15(3):177-81. PubMed ID: 15096999
[TBL] [Abstract][Full Text] [Related]
17. Comparison on Anticoagulation and Antiplatelet Aggregation Effects of Puerarin with Heparin Sodium and Tirofiban Hydrochloride: An In Vitro Study.
Li SW; Feng X; Xu H; Chen KJ
Chin J Integr Med; 2018 Feb; 24(2):103-108. PubMed ID: 29067595
[TBL] [Abstract][Full Text] [Related]
18. Recent antiplatelet drug trials in the acute coronary syndromes. Clinical interpretation of PRISM, PRISM-PLUS, PARAGON A and PURSUIT.
Alexander JH; Harrington RA
Drugs; 1998 Dec; 56(6):965-76. PubMed ID: 9878986
[TBL] [Abstract][Full Text] [Related]
19. Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study.
Nishioka T; Luo H; Fishbein MC; Cercek B; Forrester JS; Kim CJ; Berglund H; Siegel RJ
J Am Coll Cardiol; 1997 Aug; 30(2):561-8. PubMed ID: 9247533
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters.
Tóth O; Szabó C; Kecskés M; Pótó L; Nagy A; Losonczy H
Life Sci; 2006 Jun; 79(4):317-23. PubMed ID: 16480745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
